Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
MERCK Kommanditgesellschaft auf Aktien, commonly known as Merck Group, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in Darmstadt, Germany. Founded in 1668, Merck has a rich history marked by innovation and significant milestones, establishing itself as a pioneer in the life sciences sector.
The company operates globally, with major facilities across Europe, North America, and Asia, focusing on biopharmaceuticals, life science tools, and performance materials. Merck's core products include cutting-edge pharmaceuticals, laboratory supplies, and advanced materials, distinguished by their commitment to quality and scientific excellence.
With a strong market position, Merck Group is recognised for its contributions to healthcare and technology, consistently achieving notable advancements in drug development and research. This dedication to innovation solidifies its reputation as a trusted leader in the pharmaceutical industry.
+43 vs industry average
MERCK Kommanditgesellschaft auf Aktien’s score of 85 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
MERCK Kommanditgesellschaft auf Aktien (a subsidiary of Merck KGaA) is a Pharmaceutical Preparation Manufacturing company based in Germany. As of 2025, the company reported total gross carbon emissions of approximately 4.75 billion kg CO2e. This figure includes:
Looking back, in 2024, MERCK Kommanditgesellschaft auf Aktien's total emissions were approximately 5.568 billion kg CO2e, with Scope 1 at about 858 million kg CO2e, Scope 2 (market-based) at about 227 million kg CO2e, and Scope 3 at approximately 4.483 billion kg CO2e. In 2020, the company's total emissions were around 7.256 billion kg CO2e.
MERCK Kommanditgesellschaft auf Aktien has set ambitious climate commitments, which are inherited from its parent company, Merck KGaA. These Science Based Targets initiative (SBTi) approved targets include:
2030
50% reduction in Scope 1
Merck KGaA commits to reduce absolute scope 1 and 2 GHG emissions 50% by 2030 from a 2020 base year*. *The target boundary includes biogenic…
2030
50% reduction in Scope 2
Merck KGaA commits to reduce absolute scope 1 and 2 GHG emissions 50% by 2030 from a 2020 base year*. *The target boundary includes biogenic…
2030
52% reduction in scope 3 total
Merck KGaA also commits to reduce scope 3 GHG emissions 52% per euro value added within the same timeframe.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about MERCK Kommanditgesellschaft auf Aktien’s sustainability data and climate commitments
Data year: 2025
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more